Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ: IBB )

133.14 -1.11 (-0.83%)
Official Closing Price Updated: 4:15 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
The 3 Best Biotech Stocks to Buy Now: September 2023
With the biotech sector looking poised to continue its rally further, investors would do well to buy these stocks to capitalize. 
Via InvestorPlace
Industry ETFs In The Spotlight: Winners And Losers Of The Month Revealed
Via Benzinga
Topics ETFs
Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio?
It is important to track sectors of the market because trends to create volatility. For example the COVID pandemic created a diagnostics and vaccine revenue bubble that dissipated over several months. 
Via Talk Markets
Topics ETFs
Exposures COVID-19
BRICS And The Recent Headline
At a time when the world is experiencing de-globalization, an alliance of countries including Brazil, Russia, China, South Africa and possibly India is a potential threat to the west. 
Via Talk Markets
Three Lessons For Investing In Biotech Companies
Many successful blockbusters started with a small trial. But you should temper your expectations until a larger, more rigorous trial is conducted. 
Via Talk Markets
3 Top ETFs to Buy Right Now
These three exchange-traded funds could be winning plays for patient investors. 
Via The Motley Fool
The US Dollar And Long Bonds Doing The Dosey Doe
With BRICS happening ahead of Jackson Hole, it would be good to look at the technical charts on both the dollar and the long bonds. 
Via Talk Markets
5 Meme Stocks to Sell Immediately, According to AI
As we move into September, the MarketMaster AI is flashing warning signals about risky equities. Sell these meme stocks right now. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Biotechnology On Drugs
​​​​​​​Biotechnology has traded basically sideways since the start of 2023. 
Via Talk Markets
Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner
Biotech stocks are in a bear market since the IBB hit $177.37 in 2021 and is down 7.84% over five years. 
Via Talk Markets
3 Strong Biotech Performers To Watch As Sector Nears Breakout
As the IBB ETF nears a potential breakout, watch for strong performers like Regeneron Pharmaceuticals, Vertex, and Exelixis to continue outperforming. 
Via MarketBeat
Topics ETFs
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023
This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors. 
Via InvestorPlace
Weight-Loss Drug Wegovy Adds Mass To Novo Nordisk's stock, Pushing Valuation Past Denmark's GDP
Via Benzinga
CPI-Market Impact Now And Later?
A discussion about inflation, bonds, calendar ranges, and places to park your money 
Via Talk Markets
Topics Bonds Economy
Exposures Debt Markets Interest Rates
Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss
The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight increase from 3% to 3.2% last month, breaking a streak of 12 consecutive months of decline. 
Via Benzinga
Topics ETFs Economy
Exposures Interest Rates
5 Magnificent ETFs to Buy Hand Over Fist for the Second Half of 2023
These exchange-traded funds (ETFs) offer low or ultralow net expense ratios and are perfectly positioned to help investors grow their wealth. 
Via The Motley Fool
Rising Stars, Falling Trends: July's Industry ETF Winners And Losers
Via Benzinga
The July 6-Month Calendar Range SPY QQQ IWM TLT
Looking at the SPY chart, we have had 7 trading days above the range high. However, to date, SPY has not really taken off from that level and sits more in consolidation mode. 
Via Talk Markets
Now That The July 6-Month Calendar Range Is Set
As this week begins with a test of the July 6-month calendar range high, should that level break down, it could mean a substantially wide trading range in store for the small caps. 
Via Talk Markets
On A Winning Streak! Many Market Signs Appear More Bullish
This past week corporate earnings announcements picked up speed. You may recall that we mentioned the large money center Banks had announced the week before. If you did not read last week’s issue, you... 
Via Talk Markets
Major Sector ETFs Re-Set In July-Blueprint
Retail XRT is in a Distribution phase and has to clear the 200-WMA and calendar range high at 67.42. A move under 63.40 would be weak. 
Via Talk Markets
Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks
Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%. 
Via Talk Markets
Biotech Blues: Stay Balanced Through July Earnings Season
Life Science stocks lack momentum so be prepared for rebalancing and rotation shifts. 
Via Talk Markets
Moderna: Declining Performance And Relative Weakness
Moderna's value has declined by over 75% from its peak as the world moves on from the COVID-19 pandemic, leading to concerns about its investment appeal. 
Via MarketBeat
Topics ETFs
Exposures COVID-19
Biotech And Healthcare Stocks Lagging
Healthcare is a laggard with XLV down YTD but UNH is still a core position. 
Via Talk Markets
Is the Biotech Industry (IBB) Poised For A Major Breakout?
The current consolidation in the IBB signals a potential breakout might be looming as key moving averages have converged within a contracted price range. 
Via MarketBeat
Topics ETFs
Rotation Out Of Healthcare And Biotech Stocks: Age Of Disruption?
A steady rotation out of biotech and healthcare stocks into the Nasdaq-100 large-cap tech stocks can be unnerving for portfolio managers. 
Via Talk Markets
3 Biotech Stocks to Avoid Like the Plague
Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs. 
Via InvestorPlace
Sunnier Skies This Past Week, But Will It Last?
The stock market rallied out of a long sideway consolidation pattern and made a new year-to-date high as well as a positive 52-week period. The S&P 500 was up 1.71%, and the Nasdaq 100 was up 3.53% for... 
Via Talk Markets
Technical And Fundamental Analysis On US Oil Fund
Energy, gas, and oil are the underperformers this year and the main reason many call for deflation, recession, or at the very least, the end of accelerating inflation. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.